Clinical characteristic of the patients with drug resistant pulmonary tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 661s Year: 2007
Knowledge of tuberculosis patients about tuberculosis disease Source: Eur Respir J 2006; 28: Suppl. 50, 19s Year: 2006
The clinical features and treatment results of cases with multidrug resistant pulmonary tuberculosis Source: Annual Congress 2004 - Problems of resistance and HIV coinfection in tuberculosis Year: 2004
The peculiarities of course and treatment of pulmonary tuberculosis with initial drug resistance Source: Eur Respir J 2003; 22: Suppl. 45, 41s Year: 2003
The clinical and radiological comparison of new, recurrent and multidrug resistant cases of pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 169s Year: 2002
Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction Source: Eur Respir Rev 2009; 18: 295-299 Year: 2009
Clinical, epidemiologic and social peculiarities of XDR pulmonary tuberculosis (PTB) patients Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis Year: 2010
Association of genetic markers with clinical course of patients with pulmonary tuberculosis with drug resistance Source: Eur Respir J 2007; 30: Suppl. 51, 203s Year: 2007
Biochemical portrait of patients with different course of pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 645s Year: 2004
Knowledge of tuberculosis patients about tuberculosis and importance of this Source: Eur Respir J 2004; 24: Suppl. 48, 195s Year: 2004
Medico-social features of resistance development to new anti–TB drugs in patients with MDR/XDR TB Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021
Characterization of the aetiological agent in patients with pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 12s Year: 2006
Features of tuberculosis incidence and clinical forms for sarcoidosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 202s Year: 2004
The diagnostic meaning of clinical-epidemiological signs among MDR TB patients Source: Eur Respir J 2006; 28: Suppl. 50, 378s Year: 2006
When is an infectious disease? The clinical spectrum of nontuberculous mycobacterial pulmonary disease Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Year: 2019
Characteristics of the cases with primary multidrug resistance pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 652s Year: 2005
Atypical aspects of pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 507s Year: 2006
Clinical efficacy and safety of fluoroquinolone containing regimens in patients with Mycobacterium avium complex pulmonary disease Source: Eur Respir J, 55 (4) 1901240; 10.1183/13993003.01240-2019 Year: 2020
Differential diagnosis of destructive pulmonary tuberculosis in real clinical practice Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020
Treatment‘s side effects in MDR tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 454s Year: 2005